Africa Oral GLP-1 Primary-Care Workflow
One-Liner
Behavioral health integration plus stock-management software for African primary-care clinics dispensing oral GLP-1 medication for obesity management.
AI Thinking Process
Scale Shift: Hospital-specialist GLP-1 → primary-care clinic-dispensed oral. Foundayo changes physician skill requirement — clinical officer in Kenya can prescribe where specialist was required for injectable.
WHAT CHECK FAILED — CURRENT: Clinical officers in Nairobi are not prescribing Foundayo today because the drug is not available in LMIC. CURRENT cannot be filled. Fundamental timing problem.
KILLED: Foundayo not priced or distributed for LMIC. Indian generics 7+ years away. Drug supply side doesn't exist — idea is timing-broken.
Kill Reason
Fundamental timing problem: Eli Lilly has not priced or distributed Foundayo for low-and-middle-income countries. Indian generics are 7+ years away (IP protection). The drug supply side does not exist — the clinical officers in Nairobi are not prescribing Foundayo today because the drug is not available.
Risk Analysis
Risk analysis available for latest engine ideas.
What do you think?
Related ideas you can explore free:
killed: Open-source middleware (HAMi) already provides heterogeneous AI computing virtualization for free. Proprietary play is squeezed between free open-source and vertically integrated hardware vendor ecosystem.
killed: 5+ funded competitors including Cast AI ($1B valuation), OneChronos (backed by Nobel laureate), Akash Network (decentralized, 80% cheaper), Argentum AI (blockchain-settled). Market is claimed with massive capital.
killed: Template epidemic (G003) + industry-pain-form death pattern (G005) fire simultaneously. 13+ existing compliance tools. A prompt could do 80% of this.